$β^+$ radioactive nuclei created during proton therapy
Izabela Skwira-Chalot, Przemysław Sekowski, Agata Taranienko, Adam Spyra, Tomasz Matulewicz, Jan Swakoń, Joanna Matulewicz
TL;DR
This work addresses beam-range verification in proton therapy by quantifying proton-induced production of beta+-emitting nuclei $^{11}$C, $^{13}$N, and $^{15}$O in tissue-relevant elements. Using stacks of solid targets (C, BN, $SiO_2$) irradiated at $E_p<58$ MeV and detecting $511$ keV annihilation photons with $LaBr_3$ detectors, the authors extract cross sections with percent-level precision. The results generally reproduce the excitation function from prior studies across C, N, O and tissue, with detailed comparisons in each material and tissue type. They emphasize the practical significance for PET-based beam tracking, report some neutron-induced observations, and advocate a PDG-like dedicated evaluation group to standardize cross-section data for tissue-relevant reactions.
Abstract
During proton therapy, the beam flux decreases due to inelastic interactions with nuclei. At the highest energies used in proton therapy around 25\% protons initiate nuclear reactions. This report presents the cross section measurements of proton-induced production of three $β^+$ emitters -- $^{11}$C, $^{13}$N, $^{15}$O -- with half-lives between 2 and 20 minutes, using solid C, BN and SiO$_2$ targets. Stacks of up to 15 targets were irradiated simultaneously with proton beams of kinetic energy below 58 MeV at the AIC-144 cyclotron of the Institute of Nuclear Physics, Polish Academy of Sciences. The measured cross sections follow the excitation function obtained in the previous experiments, with uncertainty of a few percent.
